Publication Cover
Synthetic Communications
An International Journal for Rapid Communication of Synthetic Organic Chemistry
Volume 37, 2007 - Issue 19
913
Views
19
CrossRef citations to date
0
Altmetric
Original Articles

Improved Synthesis of Gefitinib and Erlotinib Hydrochloride‐ Anticancer Agents

, &
Pages 3409-3415 | Received 05 Feb 2007, Published online: 05 Oct 2007

References

  • Mendelsohn , J. and Baselga , J. 2003 . Status of epidermal growth factor receptor antagonists in the biology and treatment of cancer . J. Clin. Oncol. , 21 : 2787 – 2799 .
  • Ciardiello , F. , De Vita , F. , Orditura , M. , De Placido , S. and Tortora , G. 2003 . Epidermal growth factor receptor tyrosine kinase inhibitors in late stage clinical trials . Exp. Opin. Emerg. Drugs , 8 : 501 – 514 .
  • Vansteenkiste , J. F. 2004 . Gefitinib (iressa): A novel treatment for non‐small‐cell lung cancer . Expert Rev. Anticancer Ther. , 4 : 5 – 17 .
  • Bonomi , P. 2003 . Erlotinib: A new therapeutic approach for non‐small‐cell lung cancer . Expert Opin. Invest. Drugs , 12 : 1395 – 1401 .
  • Kobayashi , S. , Boggon , T. J. , Dayaram , T. , Jaenne , P. A. , Kocher , O. , Meyerson , M. , Johnson , B. E. , Eck , M. J. , Tenen , D. G. and Halmos , B. 2005 . EGFR mutation and resistance of non‐small‐cell lung cancer to gefitinib . N. Engl. J. Med. , 352 : 786 – 792 .
  • Blackhall , F. , Ranson , M. and Thatcher , N. 2006 . Where next for gefitinib in patients with lung cancer? . Lancet Oncology , 7 : 499 – 507 .
  • Marshall , J. 2006 . Implications of the mechanism of epidermal growth factor receptor inhibitors . Cancer , 107 : 1207 – 1218 .
  • Johnson , D. H. 2006 . Targeted therapies in combination with chemotherapy in non‐small cell lung cancer . Clin. Cancer Res. , 12 : 4451s – 4457s .
  • Chandregowda , V. , Rao , G. V. and Reddy , G. C. 2007 . One‐pot conversion of 2‐nitrobenzonitriles to quinazoline‐4(3H)‐ones and synthesis of gefitinib and erlotinib hydrochloride . Heterocycles , 71 : 39 – 48 . and references cited therein
  • Knesl , P. , Röseling , D. and Jordis , U. 2006 . Improved synthesis of substituted 6,7‐dihydroxy‐4‐quinazoline amines: Tandutinib, erlotinib, and gefitinib . Molecules , 11 : 286 – 287 . and references cited therein

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.